ProstateClarity Evidence Reviews
Supplement Evidence

Saw Palmetto vs Pygeum: Which Has Better Evidence?

Affiliate disclosure: some links on this site are affiliate links. If you buy through them we may earn a commission at no extra cost to you. That never changes what the research says, and we publish negative findings about products we link to. This article is informational and is not medical advice.

Rows of amber herbal tincture bottles
The short answer

Saw palmetto has the stronger evidence, and that evidence is negative: a 2023 Cochrane review of 27 studies and 4,656 men found little to no benefit.1 Pygeum looks better on paper, but its 18 trials averaged 64 days and its Cochrane review dates from 2002.2 Neither is proven to relieve prostate symptoms.

Key takeaways

  • In the 2023 Cochrane review, saw palmetto beat placebo by 0.90 points on the 35-point symptom score at 3 to 6 months. At 12 to 17 months the gap was 0.07 points, slightly in placebo's favor, which means no difference (high-certainty evidence).1
  • In the CAMUS trial, 369 men took up to three times the usual dose for 72 weeks. Saw palmetto did no better than placebo: the placebo group's score actually fell 0.79 points more, a gap too small to be meaningful.4
  • In the pygeum review (18 trials, 1,562 men), men were 2.1 times as likely to report improvement, nocturia fell 19 percent and peak flow rose 23 percent, but only 1 trial reported how it concealed treatment allocation.2
  • Pygeum is bark from the African cherry tree, listed on CITES Appendix II since 1995. The wild harvest method a 2015 research brief calls sustainable takes half the bark from the lower trunk once every seven years.13
  • In a lab test of 7 pygeum products, some held over 10,000 micrograms per gram of beta-sitosterol, against about 680 in the bark itself.15

What saw palmetto and pygeum actually are

Both are plant extracts sold for the urinary symptoms of an enlarged prostate, known as benign prostatic hyperplasia (BPH). That is where the similarity ends.

Saw palmetto comes from the berries of a small palm, 6 to 10 feet tall, native to the West Indies and the southeast coast of North America.5 Its botanical name is Serenoa repens. It is the most common ingredient in prostate supplements, according to the American Urological Association (AUA).7

Pygeum comes from the bark of Prunus africana, the African cherry or African plum, a long-lived tree of African mountain forests. The bark is peeled off, dried, powdered and turned into an extract.13

If you are not yet sure your weaker stream or extra bathroom trips come from the prostate, start with our guide to enlarged prostate symptoms in men over 45. Neither plant fixes urinary symptoms that are not prostate related.

Saw palmetto vs pygeum, side by side

Here are the two ingredients on the same grid. The evidence level is our own summary: negative means tested well and did not beat placebo; weak means small, short, older or poorly reported trials.

Saw palmetto and pygeum compared on origin, dose, research, results, safety and supply
What we comparedSaw palmettoPygeumSource
What it isBerry extract of a small palm native to the southeastern U.S. and the West IndiesBark extract of Prunus africana, an African mountain forest treeNCCIH, CGIAR brief5,13
Dose in the trialsUsually 320 mg a day of extract; CAMUS went up to 3 times that. Details in our dosage guide100 mg a day of extract, as 50 mg twice a day or 100 mg onceCAMUS, Barlet, Chatelain4,9,10
Biggest reviewCochrane 2023: 27 studies, 4,656 men, searched to 2022Cochrane 2002: 18 trials, 1,562 men, searched to 2000Cochrane1,2
Largest trialsSTEP (225 men, 1 year) and CAMUS (369 men, 72 weeks), both NIH-fundedBarlet (263 men, 60 days); trials averaged 64 daysNEJM, JAMA, Cochrane3,4,9,2
Symptom score0.90 points better than placebo at 3 to 6 months; no difference at 12 to 17 months (0.07 points, in placebo's favor)Men 2.1 times as likely to report improvement; effect size of 0.8 standard deviations in 6 studiesCochrane1,2
Urine flowNo improvement in peak flow in 3 high-quality trials (difference 0.40 mL/s)Peak flow up 23 percent; leftover urine down 24 percentCochrane8,2
Night-time urinationNo significant drop in the 72-week CAMUS trialNocturia down 19 percentCochrane8,2
SafetyWell tolerated in studies up to 3 years; mild digestive upset, dizziness, headache; does not appear to change PSASide effects mild and similar to placebo in short trials; nausea and stomach upset reported; long-term safety unknownNCCIH, Cochrane, MSK5,2,11
Supply concernsNone raised in the sources we reviewedCITES Appendix II since 1995; wild trees can die from heavy bark strippingCGIAR brief, J Ethnopharmacol13,14
Evidence levelNegative (high certainty of little to no benefit)Weak (small, short, older trials; no modern replication)Our summary of the above

Notice the pattern: the ingredient with the worse results is the one that was tested longer and in larger trials.

What the saw palmetto research found

The 2023 Cochrane review: little to no benefit

The 2023 Cochrane update included 27 studies with 4,656 men, most over 50 with moderate symptoms. Counting only trials at low risk of bias, saw palmetto improved the International Prostate Symptom Score (IPSS) by 0.90 points more than placebo at 3 to 6 months. At 12 to 17 months there was no difference: the gap was 0.07 points, and it leaned toward placebo. Quality of life did not change in a meaningful way. The reviewers rated this high-certainty evidence and concluded that saw palmetto alone "provides little to no benefits."1

To put 0.90 in context: the AUA guideline treats 3 points as the minimal detectable difference on this scale, and it expects prescription alpha blockers to improve the score by 5 to 8 points, against 2 to 4 for placebo.7

STEP: one year at the standard dose

The STEP trial, published in the New England Journal of Medicine in 2006, gave 225 men over 49 either 160 mg of saw palmetto extract twice a day or a placebo for one year. The difference in symptom scores was 0.04 points. There was also no difference in urine flow, prostate size, urine left in the bladder, quality of life or PSA.3

CAMUS: triple the dose, still no better than placebo

Maybe the standard dose was too low? CAMUS tested that. The trial, run at 11 North American sites with 369 men aged 45 and older, raised the dose to two standard doses at week 24 and three at week 48. After 72 weeks, symptom scores fell 2.20 points on saw palmetto and 2.99 points on placebo.4

That 0.79-point gap favored placebo, but it was not statistically significant, and it is well under the 3-point "minimal detectable difference" the AUA uses for this score.4,7 It does not mean the placebo pill works better. It means saw palmetto, even at triple the dose, did not beat it. Saw palmetto was also no better than placebo on any secondary measure, including nocturia and peak flow.4

The number most pages leave out. In CAMUS, the placebo group's score dropped almost 3 points with no active ingredient at all.4 A study with no placebo group would have counted a drop like that as a result.

The National Center for Complementary and Integrative Health (NCCIH) sums it up: saw palmetto "is probably not helpful" for urinary symptoms of an enlarged prostate, and hexane-extracted products, once said to work better, performed the same as the rest.5

What the pygeum research found

The 2002 Cochrane review: positive, with heavy caveats

The Cochrane review of pygeum found 18 randomized trials with 1,562 men. Compared with placebo, men on pygeum were 2.1 times as likely to report that their overall symptoms improved. Nocturia fell 19 percent, the urine left after voiding fell 24 percent, and peak flow rose 23 percent. The reviewers wrote that a standardized pygeum preparation "may be a useful treatment option."2

Now the caveats, from the same review. It counted trials of pygeum alone or combined with other ingredients, so not every result belongs to pygeum by itself. The trials lasted 64 days on average, and none ran longer than 122 days. Only 1 of the 18 described how treatment allocation was concealed. Doses and preparations varied, and results were rarely reported with standard symptom scores. There were no trials against alpha blockers or 5-alpha reductase inhibitors, the drugs doctors actually prescribe. The search ran through the year 2000.2

The largest placebo trial is from 1990

The biggest placebo-controlled trial of pygeum alone that we could find enrolled 263 men in Germany, France and Austria. They took 50 mg twice a day for 60 days. Overall urination improved in 66 percent on pygeum and 31 percent on placebo. Five men had stomach side effects, and 3 of them stopped. The lead author was listed at a French company, Laboratoires Debat, not at a university.9 In our PubMed search on September 26, 2026, we did not find a newer placebo-controlled trial of pygeum on its own.16

A 1999 trial of 209 men found 50 mg twice a day and 100 mg once a day worked about the same.10 It had no placebo group, so it speaks to dose, not to whether pygeum beats a sugar pill.

Why pygeum looks better, and why that may not hold

On paper, pygeum's numbers look better. But saw palmetto went through two long, independent, NIH-funded trials that followed men for a year or more.5,7 Pygeum's evidence is a set of short trials, all found by a search that ended in 2000.2

The saw palmetto story is a warning. The NCCIH notes that several studies suggested modest benefits, while others found it no better than placebo, even at higher doses.6 The AUA says many supplement studies share the same flaws: a single center, short duration, a poorly chosen placebo, unusual endpoints and responder-only analysis.7

That does not prove pygeum fails. It means nobody has tested it the way saw palmetto was tested. In our PubMed search, we also found no randomized trial comparing saw palmetto alone against pygeum alone.17 The honest summary: saw palmetto has high-certainty evidence of little to no benefit, and pygeum has low-quality evidence of some benefit.

Safety side by side

Saw palmetto is well tolerated and has been used safely in research for up to 3 years. Side effects are mild and infrequent: digestive symptoms, dizziness and headache. It does not appear to affect PSA readings, even at higher-than-usual amounts.5 In the Cochrane review, adverse events were about the same as with placebo (risk ratio 1.01).1

Pygeum side effects were mild and comparable to placebo in the review, with dropout rates of 13 percent on pygeum and 11 percent on placebo.2 Memorial Sloan Kettering lists nausea and stomach upset and says long-term effectiveness and safety are not known.11

For both, the NCCIH advice applies: if you take any medicine, talk with your health care provider before using any herbal product, because some herbs and medicines interact in harmful ways.5 And do not stop or change a prescribed medicine without your doctor.

The tree behind pygeum: a sustainability question

Prunus africana has been listed on Appendix II of the Convention on International Trade in Endangered Species (CITES) since 1995. That listing means the species is not necessarily threatened with extinction now, but may become so unless trade is closely controlled through annual quotas.13

How the bark is harvested

According to a 2015 brief from four research centers (CIFOR, ICRAF, Bioversity International and Wageningen), taking a large amount of bark from one tree leads to disease and death. The method that appears sustainable for wild trees, "two quarters," harvests only trees at least 30 cm across, peeling half the bark between chest height and the first branch, once every seven years. Even this can kill trees. Planted trees need about 15 to 35 years before harvest.13

How big the trade is

World trade in the bark tripled from 2003 to 2005, to 2,815 tons.13 A 2016 study in the Journal of Ethnopharmacology describes a European Union import ban from 2007 to 2011, and found wild populations vulnerable even inside some protected areas. In 2012, harvesters in Mount Cameroon National Park earned less than 1 U.S. dollar a day from the bark. The authors call for traceable supply chains based on cultivated trees.14

If you choose pygeum, ask the seller whether the bark comes from cultivated trees and was traded under a CITES permit.

What is actually in the bottle

A pygeum capsule is not ground bark. Chemists at Oberlin College compared 4 bark samples with 7 commercial pygeum products. Bark held about 680 micrograms of beta-sitosterol per gram; some products held more than 10,000. Bark held about four times more ferulic acid. The products were not mislabeled: their beta-sitosterol generally matched the phytosterol amount on the label.15 The point is that what you buy is a processed, concentrated extract whose chemistry can differ a lot from the bark, and from one brand to the next.

That matters because both ingredients also turn up inside multi-ingredient blends. If a label lists pygeum in a "proprietary blend" without its own milligram number, you cannot know whether you get anything close to the 100 mg a day used in the trials.9,10 Our guide on how to read a prostate supplement label walks through this line by line. For saw palmetto, the extract versus powder question and the trial doses are covered in our saw palmetto dosage guide.

Combining the two has no better evidence: in the 2023 Cochrane review, blends that included saw palmetto "may result in little to no difference" in symptoms (low-certainty evidence).1

Red flags: see a doctor before you try either one

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says to tell a health care professional right away if you cannot urinate at all, have painful, frequent and urgent urination with fever and chills, have blood in your urine, or have great discomfort or pain in your lower abdomen or urinary tract. It also notes that urinary symptoms can come from bladder problems, infections, prostatitis or prostate cancer, not only BPH.12

What doctors use instead

The AUA's 2026 guideline says "behavioral and lifestyle interventions should be explored before or alongside pharmacologic treatment."18 Its previous version lists the habits: fewer fluids before bed, less caffeine and alcohol, avoiding constipation, more activity, timed voiding and double voiding. For bothersome moderate to severe symptoms, it recommends alpha blockers such as tamsulosin, with its highest evidence grade.7

If you are already on a prescription and wondering whether a plant could replace it, read our comparison of natural alternatives to Flomax first. Do not stop or change a prescribed medicine without your doctor.

Where a supplement fits

A supplement does not come first, and neither of these is proven to work. If your exam and urine test were clean, your symptoms are mild, and you still want to try something while you work on your habits, pygeum has more encouraging data than saw palmetto alone, but that data is older, shorter and weaker. Talk it over with your doctor first, especially if you take other medicines. If you do try a product, pick one that lists each ingredient in milligrams, so you can compare it with the doses used in the trials, and judge it by your symptom score, not by how you feel in the first week.

If you are comparing labels

ProtoFlow contains no pygeum, and its saw palmetto is 84.5 mg a day, about a quarter of the 320 mg used in the trials above. It is not a way to test either herb at a studied dose.

It is a 14-ingredient formula built mostly on herbs sold for male vitality, such as epimedium, damiana and tribulus. Its maker says it "supports the normal functions of the bladder, prostate and reproductive system".

Our review checks that claim against the full label, the published research and the refund terms, so you can decide whether that mix is what you are looking for.

See the full ProtoFlow label analysis

A practical plan for this week

  1. Score your symptoms today. Fill out the International Prostate Symptom Score, the 7-question scale the AUA uses, and write down the number.7
  2. Start the habits tonight. Fewer fluids in the evening, less caffeine and alcohol, and double voiding.7
  3. If you already take saw palmetto or pygeum, find the milligrams per ingredient on the label. No number means you cannot compare it with the trials.
  4. Set a fixed window. If you and your doctor agree to try pygeum, the trials ran about 2 months.2 Score yourself again at the end, and remember that a placebo alone can move the score 2 to 4 points.7
  5. Watch for the red flags above, and get care right away if any appear.12

If waking up at night is the main problem, see how many times a night is normal to urinate. Much night-time urination has nothing to do with the prostate.

Frequently asked questions

Which is better for an enlarged prostate, saw palmetto or pygeum?

Neither is proven. Saw palmetto has the stronger evidence, and it is negative: a 2023 Cochrane review of 27 studies and 4,656 men found little to no benefit. Pygeum has more encouraging results, with men 2.1 times as likely to report improvement, but its 18 trials were small, averaged 64 days, and were reviewed in 2002.

Has anyone compared saw palmetto and pygeum head to head?

We could not find a randomized trial comparing saw palmetto alone against pygeum alone in a PubMed search on September 26, 2026. Each was tested against placebo, and the Cochrane review of pygeum found no trials comparing it with prescription drugs either.

Does pygeum help with getting up at night to urinate?

In the 2002 Cochrane review, pygeum reduced nocturia by 19 percent compared with placebo, but the trials were short and poorly reported. Saw palmetto did not significantly reduce night-time urination in the 72-week CAMUS trial. Much night-time urination is not caused by the prostate at all.

Is pygeum safe to take?

In short trials, side effects were mild and similar to placebo, and dropout rates were 13 percent on pygeum against 11 percent on placebo. Memorial Sloan Kettering lists nausea and stomach upset and says long-term safety is not known. If you take any medicine, talk with your health care provider first.

Do saw palmetto or pygeum affect PSA test results?

According to the National Center for Complementary and Integrative Health, saw palmetto does not appear to affect PSA readings, even when taken in higher-than-usual amounts. The STEP trial also found no difference in PSA after one year.

Can I take saw palmetto and pygeum together?

The evidence does not show a clear benefit. In the 2023 Cochrane review, blends that combined saw palmetto with other plant extracts may result in little to no difference in symptoms compared with placebo, based on low-certainty evidence. Ask your doctor before combining supplements with any medicine.

Is pygeum endangered?

Prunus africana, the tree pygeum comes from, has been listed on CITES Appendix II since 1995. That means it is not necessarily threatened with extinction now but may become so unless trade is closely controlled. Heavy bark stripping can kill wild trees.

How much pygeum was used in the studies?

The main trials used 100 mg of pygeum extract a day, given as 50 mg twice a day or 100 mg once a day. A 1999 trial of 209 men found the two schedules worked about the same over two months.

Sources

  1. Franco JVA, Trivisonno L, Sgarbossa NJ, et al. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement. Cochrane Database of Systematic Reviews. 2023;6:CD001423. PMID 37345871. https://pubmed.ncbi.nlm.nih.gov/37345871/
  2. Wilt T, Ishani A, MacDonald R, Rutks I, Stark G. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2002;(1):CD001044. PMID 11869585. https://pubmed.ncbi.nlm.nih.gov/11869585/
  3. Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia (STEP trial). New England Journal of Medicine. 2006;354(6):557-566. PMID 16467543. https://pubmed.ncbi.nlm.nih.gov/16467543/
  4. Barry MJ, Meleth S, Lee JY, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial (CAMUS). JAMA. 2011;306(12):1344-1351. PMID 21954478. https://pubmed.ncbi.nlm.nih.gov/21954478/
  5. National Center for Complementary and Integrative Health (NIH). Saw Palmetto. Last updated April 2025. https://www.nccih.nih.gov/health/saw-palmetto
  6. National Center for Complementary and Integrative Health (NIH). 5 Tips: What You Should Know About Complementary Health Approaches for BPH. https://www.nccih.nih.gov/health/tips/tips-what-you-should-know-about-complementary-health-approaches-for-bph
  7. American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2021, amended 2023), unabridged. Previous version, replaced on May 7, 2026. https://www.auanet.org/documents/Guidelines/PDF/2023%20Guidelines/BPH%20Unabridged%2002-20-24%20Final.pdf
  8. Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2012;12:CD001423. PMID 23235581. https://pubmed.ncbi.nlm.nih.gov/23235581/
  9. Barlet A, Albrecht J, Aubert A, et al. Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: a placebo-controlled double-blind multicenter study. Wiener Klinische Wochenschrift. 1990;102(22):667-673. PMID 1702916. https://pubmed.ncbi.nlm.nih.gov/1702916/
  10. Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia. Urology. 1999;54(3):473-478. PMID 10475357. https://pubmed.ncbi.nlm.nih.gov/10475357/
  11. Memorial Sloan Kettering Cancer Center, About Herbs. Pygeum. Updated January 29, 2021. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/pygeum
  12. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Enlarged Prostate (Benign Prostatic Hyperplasia). Last reviewed June 2024. https://www.niddk.nih.gov/health-information/urologic-diseases/prostate-problems/enlarged-prostate-benign-prostatic-hyperplasia
  13. Ingram V, Loo J, Vinceti B, et al. Ensuring the future of the pygeum tree (Prunus africana): briefing on cultivation and harvesting. LEI Wageningen UR, CIFOR, Bioversity International and ICRAF (CGIAR Research Program on Forests, Trees and Agroforestry). April 2015. https://cgspace.cgiar.org/bitstreams/a303f896-5030-4587-a169-7e238f36373d/download
  14. Cunningham A, Anoncho VF, Sunderland T. Power, policy and the Prunus africana bark trade, 1972-2015. Journal of Ethnopharmacology. 2016;178:323-333. PMID 26631758. https://pubmed.ncbi.nlm.nih.gov/26631758/
  15. Thompson RQ, Katz D, Sheehan B. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health. Journal of Pharmaceutical and Biomedical Analysis. 2019;163:162-169. PMID 30316061. https://pubmed.ncbi.nlm.nih.gov/30316061/
  16. PubMed search: pygeum or Prunus africana, benign prostatic hyperplasia, randomized controlled trials and reviews (run September 26, 2026). https://pubmed.ncbi.nlm.nih.gov/?term=%28pygeum+OR+%22Prunus+africana%22%29+AND+benign+prostatic+hyperplasia+AND+%28randomized+controlled+trial%5Bpt%5D+OR+meta-analysis%5Bpt%5D+OR+systematic+review%5Bpt%5D%29
  17. PubMed search: saw palmetto (Serenoa) and pygeum (Prunus africana) together (run September 26, 2026). https://pubmed.ncbi.nlm.nih.gov/?term=%28Serenoa+OR+%22saw+palmetto%22%29+AND+%28Pygeum+OR+%22Prunus+africana%22%29
  18. American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026), Parts I to III. Released May 7, 2026; replaces the 2021 guideline amended in 2023. https://www.auanet.org/2026BPHGuideline. Recommendations as quoted by Guideline Central: https://www.guidelinecentral.com/insights/may-2026-aua-lowerurinarytractsymptoms-guideline-video/
Alice Hess

About the author

Alice Hess is a health researcher and wellness writer at ProstateClarity. She is not a doctor, a nurse, a nutritionist or any kind of licensed clinician, and nothing here is medical advice. She started this work because of her father: at 76 he was getting up several times a night, and the research she did for him helped him get back to sleeping through the night. One man's story is not evidence, which is why every guide here is built on published research. She reads labels, primary research and regulatory limits, and publishes the numbers manufacturers leave out. More about her work and how these articles are researched.

Found an error? Write to contact@prostateclarity.com with the sentence and the source that contradicts it. Corrections are made in the article with the date noted.

Medical disclaimer This article is for general information only and is not medical advice, diagnosis or treatment. Saw palmetto, pygeum and other dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and no statement here should be read as a promise of any result. Urinary symptoms in men can have many causes, some of them serious. Do not stop or change a prescribed medicine without your doctor. Talk with a qualified healthcare professional before starting, stopping or changing any supplement or medication, especially if you take prescription drugs or have surgery scheduled. If you have blood in your urine, cannot urinate, or have fever with urinary symptoms, seek medical care promptly.